查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577236

2030 年辅助人工心臟(VAD) 市场预测：按产品、设计、流量类型、应用、最终用户和地区进行的全球分析

Ventricular Assist Devices Market Forecasts to 2030 - Global Analysis By Product, Design, Type of Flow, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球辅助人工心臟(VAD) 市场规模将达到 36 亿美元，预计到 2030 年将达到 107 亿美元，预测期内复合年增长率为 19.6%。

称为辅助人工心臟(VAD) 的机械帮浦可帮助心室将血液泵送到全身并支持心臟功能。它经常被不适合接受移植手术、患有严重心臟衰竭或正在等待心臟移植的患者使用。辅助人工心臟可插入一个或两个心室，最常见的是左心室 (LVAD)、右心室 (RVAD) 或两者 (BiVAD)。这些可以提高患者的生活水准，增加血流量，并减轻心臟负担。

根据美国心臟协会 (AHA) 的数据，预计到 2030 年，美国心臟衰竭的盛行率将显着增加，患者数量将超过 800 万人。 2020年，全球整体将有超过550万人受到心臟衰竭的影响。老年人罹患心臟衰竭的风险较高。因此，人口老化的增加也在加速这种疾病的传播。

全球心臟衰竭盛行率

在富裕国家，心臟衰竭影响 1-2% 的人口。预测表明，到 2030 年，大约 800 万美国人可能会受到这种疾病的影响。心臟衰竭患者数量的增加是增加辅助人工心臟需求的一个主要因素。此外，老年人口中常见的慢性疾病，如糖尿病和高血压，是心臟衰竭患者增加的主要原因，而可用心臟捐赠者的缺乏也增加了对辅助人工心臟的需求。

与移植相关的风险

出血风险增加是辅助人工心臟植入的手术后果之一，而抗凝血剂的使用可能会使情况变得更糟。控制器和电源等外部组件可能成为感染疾病的切入点，导致严重问题并增加移植后死亡率。血栓症是与设备相关的后果之一，需要仔细监测抗凝血治疗水平，因为它可能导致中风和帮浦衰竭。此外，心臟负荷增加引起的右心室功能障碍可能会使患者的治疗结果复杂化，需要进一步治疗。

辅助人工心臟技术持续创新

技术的进步导致了更坚固、更紧凑的设备的开发，提高了患者的舒适度和移动性。生物相容性的进步降低了血栓症和感染疾病的风险，减少了患者采用的障碍。由于小型化和侵入性较小，辅助人工心臟装置已被更多患者广泛使用，恢復时间更短，植入过程更简单。

报销政策和保险范围不足

辅助人工心臟不仅需要植入手术，还需要术后护理，这可能很昂贵。如果患者因保险范围不足而必须支付大笔自付费用，他们可能不愿意选择辅助人工心臟治疗。获得医疗服务的机会不足会导致医疗干预措施的延迟或放弃、健康状况不佳以及长期医疗费用增加，最终减少辅助人工心臟的市场需求。

COVID-19 的影响：

COVID-19 大流行对辅助人工心臟(VAD) 市场产生了负面影响，导致择期手术显着延迟并降低了装置利用率。由于封锁和旅行限制，辅助人工心臟移植的数量减少，许多患者出于安全考虑而推迟了治疗。结果，对辅助人工心臟的需求减少，影响了製造商和医疗保健提供者的收益。然而，随着限制的放鬆，预计患者就诊和手术将有所恢復，这可能会推动随后的市场成长。

预计这两个辅助人工心臟(VAD) 细分市场将在预测期内成为最大的细分市场

由于 BiVAD 技术的需求增加和进步，例如可提高全辅助人工心臟心臟 (TAH) 植入场景中的设备性能和效用的气动驱动系统，BiVAD 细分市场预计将在预测期内实现最高增长。 BiVAD 可以实现更好的血流动力学支援、改善生活品质、提高存活率以及提高患者和医生的接受度。

预计桥接移植领域在预测期内复合年增长率最高。

由于在等待心臟移植期间保持患者稳定的关键功能，移植领域预计在预测期内将经历最高的复合年增长率。辅助人工心臟可提供 2 至 6 个月必要的机械性支持，进而改善患者的治疗效果。加深对 BTT 疗法有效性的了解将有助于其在心臟衰竭治疗中的广泛应用。

比最大的地区

这是因为北美心臟衰竭发病率的增加和医疗设备技术的开拓共同推动了对辅助瓣膜装置 (VAD) 作为到达目的地和移植的桥接治疗的需求。此外，当可供移植的捐赠者心臟不足时，辅助人工心臟提供了重要的替代品，帮助患者永久生存或等待移植。

复合年增长率最高的地区：

由于中国、印度、日本和韩国对现代医疗技术和医疗保健基础设施的投资增加，预计亚太地区在预测期内将呈现最高成长率。由于意识的提高和诊断能力的提高，对复杂心臟衰竭管理解决方案的需求不断增长。由于技术发展，包括开发较小、更有效、问题更少的设备，亚太地区辅助人工心臟(VAD) 市场正在不断扩大。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球辅助人工心臟(VAD) 市场：依产品

  • LVAD
  • RVAD
  • BiVAD
  • 全人工心臟

第六章全球辅助人工心臟(VAD) 市场：设计

  • 植入式辅助人工心臟
  • 经皮辅助人工心臟（VAD）

第七章全球辅助人工心臟（VAD）市场：依流量类型

  • 脉动流VAD
  • 连续流VAD

第八章全球辅助人工心臟(VAD) 市场：依应用分类

  • BTT（Bridge to Transplant）
  • DT（Destination Therapy）
  • BTR（Bridge to Recovery）
  • BTC (Bridge to candidacy)

第 9 章全球辅助人工心臟(VAD) 市场：依最终使用者分类

  • 医院
  • 心臟外科中心
  • 居家照护机构
  • 其他最终用户

第10章全球辅助人工心臟（VAD）市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • Abiomed Inc.
  • BiVACOR Inc.
  • Abbott Laboratories
  • Berlin Heart GmbH
  • Calon Cardio
  • Medtronic PLC
  • SynCardia Systems LLC
  • Terumo Corporation
  • Jarvik Heart Inc.
  • ReliantHeart, Inc.
  • Sun Medical Technology Research Corp
Product Code: SMRC27556

According to Stratistics MRC, the Global Ventricular Assist Devices Market is accounted for $3.6 billion in 2024 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 19.6% during the forecast period. Mechanical pumps called Ventricular Assist Devices (VADs) help the ventricles pump blood to the body, hence supporting heart function. Patients who are not candidates for transplant surgery, have significant heart failure, or are awaiting a heart transplant frequently utilize them. VADs can be inserted into one or both ventricles, the most frequent being the left ventricle (LVAD), right ventricle (RVAD), or both (BiVAD). They raise the standard of living for patients, increase blood flow, and lessen cardiac strain.

According to the American Heart Association (AHA), the prevalence of heart failure is expected to increase at a significant growth rate by 2030 in the U.S., and is projected to reach over 8 million patients. In 2020, globally, more than 5.5 million individuals were affected by heart failure. Old-age people are at high risk of HF. Therefore, the increasing geriatric population has also been fueling the disease prevalence.

Market Dynamics:

Driver:

Global prevalence of heart failure

In wealthy nations, heart failure affects 1-2% of the population; by 2030, nearly 8 million Americans may be affected, according to forecasts. The rise in heart failure instances is a major factor driving the need for VADs. Moreover chronic illnesses that are common in aging populations, such as diabetes and hypertension, are the primary cause of the rise in heart failure patients Hence the demand for VADs is increased by the scarcity of available cardiac donors.

Restraint:

Risks associated with implantation

Increased bleeding risks are one of the surgical consequences associated with VAD implants, and anticoagulant medication may make matters worse. External parts such as controllers and power supplies can act as sites of entry for infections, which can cause serious problems and higher post-transplant mortality rates. Thrombosis is one device-related consequence that requires cautious anticoagulation level monitoring because it might cause strokes or pump failure. Furthermore, right ventricular dysfunction brought on by an increased stress on the heart may complicate patient outcomes and necessitate further procedures.

Opportunity:

Continuous innovations in VAD technology

Progress in technology has resulted in more robust and compact devices, enhancing the comfort and mobility of patients. Advances in biocompatibility have lowered risks of thrombosis and infections, which has lowered obstacles to patient adoption. VAD therapy is now more widely available to a larger range of patients thanks to the less invasive nature of miniaturization, which also makes recovery times quicker and implantation processes simpler.

Threat:

Inadequate reimbursement policies and insurance coverage

VADs require implantation procedures as well as post-operative care, which can be costly. Patients may be discouraged from choosing VAD therapy if they have to pay large out-of-pocket costs due to inadequate insurance coverage. Insufficient access to care can lead to postponed or abandoned medical interventions, deteriorating health outcomes and increasing long-term healthcare expenses, ultimately decreasing market demand for VADs.

Covid-19 Impact:

The COVID-19 pandemic negatively impacted the Ventricular Assist Devices (VAD) market by causing significant delays in elective surgeries and a reduction in device utilization. Lockdowns and travel restrictions led to fewer VAD transplants, as many patients postponed seeking treatment due to safety concerns. This resulted in decreased demand for VADs, affecting revenue for manufacturers and healthcare providers. However, as restrictions eased, a rebound in patient visits and procedures is anticipated, potentially revitalizing market growth in subsequent years.

The biventricular assist devices segment is expected to be the largest during the forecast period

The biventricular assist devices segment is expected to be the largest during the forecast period owing to increased demand and advancements in BiVAD technology, such as pneumatically driven systems that improve device performance and usefulness in total artificial heart (TAH) transplant scenarios. Better hemodynamic support, improved quality of life, increased survival rates, and more patient and physician acceptance are all achieved by BiVADs.

The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period

The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period owing to its vital function in keeping patients stable while they await heart transplants. VADs improve patient outcomes by providing necessary mechanical support for a period of two to six months. A greater understanding of the effectiveness of BTT therapy promotes its broader use in the treatment of heart failure.

Region with largest share:

North America is expected to have the largest market share over the projection period due to the growing rate of heart failure in North America combined with technological developments in medical devices has raised demand for valve assist devices (VADs) as destination and bridge-to-transplant therapies. Moreover VADs offer a vital substitute in the event that there are insufficient donor hearts available for transplantation, assisting patients in surviving either permanently or while they wait for a transplant.

Region with highest CAGR:

Asia Pacific is anticipated to witness the highest rate of growth during the forecast period owing to increased investment in modern medical technology and healthcare infrastructure by China, India, Japan, and South Korea is contributing to the growing use of VADs. The need for sophisticated heart failure management solutions is being driven by rising awareness and enhanced diagnostic capabilities. The Asia Pacific VAD market is expanding as a result of technological developments that include the development of smaller, more effective devices with fewer issues.

Key players in the market

Some of the key players in Ventricular Assist Devices Market include Abiomed Inc., BiVACOR Inc, Abbott Laboratories, Berlin Heart GmbH, Calon Cardio, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, Jarvik Heart Inc., ReliantHeart, Inc. and Sun Medical Technology Research Corp .

Key Developments:

In September 2024, Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic.

In September 2024, Abbott announced U.S. availability of Lingo(TM), the company's first continuous glucose monitoring system available without a prescription. Lingo is based on Abbott's world-leading FreeStyle Libre(R) continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally.

In September 2024, Medtronic plc announced at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations.

Products Covered:

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Biventricular Assist Device
  • Total Artificial Heart

Designs Covered:

  • Implantable Ventricular Assist Devices
  • Transcutaneous Ventricular Assist Devices

Type of Flows Covered:

  • Pulsatile Flow VAD
  • Continuous Flow VAD

Applications Covered:

  • Bridge-to-Transplant
  • Destination Therapy
  • Bridge-to-Recovery
  • Bridge-to-Candidacy

End Users Covered:

  • Hospitals
  • Cardiac Surgery Centers
  • Home Care Agencies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ventricular Assist Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Left Ventricular Assist Device
  • 5.3 Right Ventricular Assist Device
  • 5.4 Biventricular Assist Device
  • 5.5 Total Artificial Heart

6 Global Ventricular Assist Devices Market, By Design

  • 6.1 Introduction
  • 6.2 Implantable Ventricular Assist Devices
  • 6.3 Transcutaneous Ventricular Assist Devices

7 Global Ventricular Assist Devices Market, By Type of Flow

  • 7.1 Introduction
  • 7.2 Pulsatile Flow VAD
  • 7.3 Continuous Flow VAD

8 Global Ventricular Assist Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Bridge-to-Transplant
  • 8.3 Destination Therapy
  • 8.4 Bridge-to-Recovery
  • 8.5 Bridge-to-Candidacy

9 Global Ventricular Assist Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Cardiac Surgery Centers
  • 9.4 Home Care Agencies
  • 9.5 Other End Users

10 Global Ventricular Assist Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abiomed Inc.
  • 12.2 BiVACOR Inc.
  • 12.3 Abbott Laboratories
  • 12.4 Berlin Heart GmbH
  • 12.5 Calon Cardio
  • 12.6 Medtronic PLC
  • 12.7 SynCardia Systems LLC
  • 12.8 Terumo Corporation
  • 12.9 Jarvik Heart Inc.
  • 12.10 ReliantHeart, Inc.
  • 12.11 Sun Medical Technology Research Corp

List of Tables

  • Table 1 Global Ventricular Assist Devices Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 4 Global Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 5 Global Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 6 Global Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 7 Global Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 8 Global Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 9 Global Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 10 Global Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 11 Global Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 12 Global Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 13 Global Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 14 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 15 Global Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 16 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 17 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 18 Global Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 19 Global Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 20 Global Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 21 Global Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 22 Global Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 23 North America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 24 North America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 25 North America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 26 North America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 27 North America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 28 North America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 29 North America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 30 North America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 31 North America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 32 North America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 33 North America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 34 North America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 35 North America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 36 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 37 North America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 38 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 39 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 40 North America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 41 North America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 42 North America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 43 North America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 44 North America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 45 Europe Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 46 Europe Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 47 Europe Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 48 Europe Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 49 Europe Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 50 Europe Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 51 Europe Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 52 Europe Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 53 Europe Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 54 Europe Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 55 Europe Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 56 Europe Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 57 Europe Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 58 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 59 Europe Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 60 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 61 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 62 Europe Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 63 Europe Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 64 Europe Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 65 Europe Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 66 Europe Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 67 Asia Pacific Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 68 Asia Pacific Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 69 Asia Pacific Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 70 Asia Pacific Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 71 Asia Pacific Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 72 Asia Pacific Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 73 Asia Pacific Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 74 Asia Pacific Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 75 Asia Pacific Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 76 Asia Pacific Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 77 Asia Pacific Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 78 Asia Pacific Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 79 Asia Pacific Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 80 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 81 Asia Pacific Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 82 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 83 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 84 Asia Pacific Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 85 Asia Pacific Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 86 Asia Pacific Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 87 Asia Pacific Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 88 Asia Pacific Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 89 South America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 90 South America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 91 South America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 92 South America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 93 South America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 94 South America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 95 South America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 96 South America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 97 South America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 98 South America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 99 South America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 100 South America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 101 South America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 102 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 103 South America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 104 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 105 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 106 South America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 107 South America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 108 South America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 109 South America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 110 South America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 111 Middle East & Africa Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
  • Table 112 Middle East & Africa Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 113 Middle East & Africa Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
  • Table 114 Middle East & Africa Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
  • Table 115 Middle East & Africa Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
  • Table 116 Middle East & Africa Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
  • Table 117 Middle East & Africa Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
  • Table 118 Middle East & Africa Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
  • Table 119 Middle East & Africa Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
  • Table 120 Middle East & Africa Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
  • Table 121 Middle East & Africa Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
  • Table 122 Middle East & Africa Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
  • Table 123 Middle East & Africa Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 124 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
  • Table 125 Middle East & Africa Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
  • Table 126 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
  • Table 127 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
  • Table 128 Middle East & Africa Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 129 Middle East & Africa Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 130 Middle East & Africa Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
  • Table 131 Middle East & Africa Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
  • Table 132 Middle East & Africa Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)